Presented for research literature review only Lenney W et al
Saxenda (liraglutide) injection 3 mg is an injectable prescription medicine used for adults with excess weight (BMI 27) who also have weight-related medical problems or obesity (BMI 30), and children aged 12-17 years with a body weight above 132 pounds (60 kg) and obesity to help them lose weight and keep the weight off
These findings support the notion that targeting lipid metabolic dysfunction may offer a feasible strategy to mitigate CaOx crystal-induced kidney damage
Related Reading Glp 1 For Type 2 Diabetes Microdose Glp 1 2 Glp 1 Vs Tirzepatide 2 Oral Glp 1 2 Medical and Editorial Standards Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims
It's about execution discipline